Core Insights - Canadian marijuana stocks are gaining investor attention due to ongoing developments in the global cannabis market, with companies like Tilray, Canopy Growth, and Aurora Cannabis leading the way [1][2] Company Summaries Canopy Growth Corporation - Canopy Growth is recognized for its commitment to quality and innovation, offering a diverse range of cannabis products for medical and recreational use [3][6] - The company has expanded its retail locations and production facilities, establishing a strong presence in Canada and key U.S. states like Colorado and California [5][6] - Financially, Canopy Growth reported a gross margin improvement to 28% from -11% year-over-year, with total net revenue of $79 million, a 7% decline from the previous year, but a significant 81% increase in international cannabis revenue [7][8] Tilray, Inc. - Tilray is a prominent player in the global cannabis industry, focusing on research, cultivation, and distribution across medical and adult-use markets [9][10] - The company achieved a 30% increase in net revenue to $188.3 million, with cannabis revenue rising by 33% to $63.4 million, despite a net loss of $105 million, reduced from $1.2 billion the previous year [10][11] - Tilray is actively reducing debt and improving liquidity, with a focus on diversifying its portfolio through strategic acquisitions [11][12] Aurora Cannabis Inc. - Aurora Cannabis has established a strong reputation in the cannabis industry, focusing on both medical and recreational markets [13][15] - The company reported consolidated revenue of $64.4 million, up from $61.1 million, driven by global medical cannabis growth, with adjusted gross margins expanding to 50% [16][17] - Aurora has reduced its net loss to $25.2 million from $62.4 million the previous year, with expectations of continued positive adjusted EBITDA into the fourth quarter of 2024 [17] Industry Overview - The global cannabis industry is on a growth trajectory, particularly in the U.S., driven by legal reforms and increasing social acceptance [2][19] - The potential for U.S. federal legalization could significantly boost the market, opening up interstate commerce and larger-scale operations [19] - Investors are advised to monitor technical analysis and maintain a diversified portfolio to capitalize on growth opportunities while managing risks [2][18]

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 20-F (Mark One) ☐ REGISTRATION STATEMENT PURSUANT TO SECTION 12(b) OR (g) OF THE SECURITIES EXCHANGE ACT OF 1934 OR ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2023. OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 OR ☐ SHELL COMPANY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES ...

If even Tilray can't make money from marijuana, what hope does any company have?Tuesday is turning into a lousy day to own marijuana stocks, as bad news from cannabis company Tilray Brands (TLRY -19.30%) is taking a toll on pretty much every other marijuana stock out there. Tilray reported a miss on sales this morning and a $0.12 per-share net loss.Shares of Cronos Group (CRON -1.86%), Canopy Growth (CGC -8.74%), and Aurora Cannabis (ACB -8.55%) are all suffering as a result, down 3.5%, 7.8%, and 8.5%, resp ...

What is the safest way to bet on SAFER marijuana banking reform?Marijuana stocks glowed green again on Monday due to news of progress on marijuana banking reform in Congress. According to Senate Majority Leader Chuck Schumer (D-N.Y.), the Senate is on course to pass new cannabis banking rules in the not-too-distant future. And while we've heard this song before, investors are starting to hum along again anyway.As of 10:35 a.m. ET, shares of Canopy Growth (CGC -0.07%) were up about 0.3%, Cronos Group (CRON 0 ...

Depending on who you ask, a recession is either right around the corner or the stock market is ready to rattle off a seismic bull run. As always, the answer is probably in the middle of those two extremes. But due to uncertainty surrounding the Federal Reserve's interest rate cuts, investors are stuck in a holding pattern until more data defines the country's fiscal path.Since bargains become popular when times are uncertain, we’d like to introduce a new weekly segment: Cheap Seats. Every week, we will prof ...

Aurora Cannabis Inc (TSE: ACB) is up another 35% on Wednesday after an industry executive became president of the Cannabis Council of Canada.What does it mean for $ACB? Copy link to section C3 picked Paul McCarthy as its president today. McCarthy has previously served as the head of corporate policy and international implementation at peer Canopy Growth. According to Rick Savone – a senior vice president of Aurora Cannabis who also chairs the Cannabis Council of Canada:We are confident that under his leader ...

Cannabis stocks are on the move Tuesday after the Florida Supreme Court approved the ability to add recreational marijuana use to the state’s November ballot.This measure will have residents of Florida voting for or against a new amendment that would allow the use of the drug. The court voted five to two in favor of allowing the amendment to be on the ballot.Here’s what Justice Jamie Grosshans said about the decision in a statement collected by CBS News.“Our role is narrow — we assess only whether the amend ...

Key PointsSeveral cannabis stocks surged dramatically over the previous month, igniting the sector as gains reached double- to even triple-digits in some cases.Vice President Kamala Harris supports federal marijuana legalization and urged the DEA to reschedule the drug.Germany passed a law fully legalizing marijuana, effective April 1, including possession, home growing, and distribution among social clubs.5 stocks we like better than Canopy GrowthVarious themes and sectors garnered buzz and attention as th ...

NASDAQ | TSX: ACB The Expected De-scheduling of Cannabis to Fuel Expansion of the Medical Cannabis Market in Germany EDMONTON, AB, April 1, 2024 /PRNewswire/ -- Aurora Cannabis Inc. (NASDAQ: ACB) (TSX: ACB) – a Canadian based leading global medical cannabis company, applauds the German government's final endorsement of cannabis legalization, marking a significant step forward in bolstering patient access to medical cannabis with the official passing of the Cannabis Act. This change presents long overdue ref ...

Milestone Achievement Signals Company's Commitment to Solidifying its Leadership in the Australian Market                                                                                            NASDAQ | TSX: ACB EDMONTON, AB, March 20, 2024 /PRNewswire/ - Aurora Cannabis Inc. (NASDAQ: ACB) (TSX: ACB) – The Canadian based leading global medical cannabis company has received Good Manufacturing Practice (GMP) certification from Australia's Therapeutic Goods Administration (TGA) for its Canadian production f ...